Education
About Us
Working with TipRanks
Follow Us
Dr. Martens Plc (GB:DOCS)
LSE:DOCS
DOCS Stock Chart & Stats
62.55 p
-1.05 p(-1.49%)
At close: 4:00 PM EST
62.55 p
-1.05 p(-1.49%)
Day’s Range― - ―
52-Week Range43.02 p - 100.87 p
Previous CloseN/A
Volume189.83K
Average Volume (3M)1.82M
Market Cap
£604.61M
Enterprise Value906.01M
Total Cash (Recent Filing)£95.70M
Total Debt (Recent Filing)£397.10M
Price to Earnings (P/E)―
Beta1.67
Next Earnings
May 28, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend Yield3.36%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding967,343,750
10 Day Avg. Volume1,078,739
30 Day Avg. Volume1,820,978
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.34
Price to Sales (P/S)0.62
P/FCF Ratio2.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£93.75Price Target Upside49.88% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.04
Revenue Forecast (FY)£773.90M
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSustained free cash flow improvement strengthens financial flexibility. Robust FCF supports reinvestment in stores and DTC, funds debt paydown, and allows dividends/share plans without relying on volatile earnings, enhancing multi-quarter resilience and strategic optionality.
High Gross Profit MarginA near-65% gross margin reflects durable product pricing power and brand premium. High gross margins cushion operating performance through marketing or cost cycles, enabling sustained investment in product and DTC channels while preserving room for margin recovery if volume softens.
Debt Reduction & Manageable LeverageReducing net bank debt and a sub-3x net debt/EBITDA ratio materially improves balance sheet resilience. Lower leverage reduces interest burden, increases strategic flexibility for retail expansion or marketing, and decreases refinancing risk across the next several quarters.
Bears Say
Declining Revenue And ProfitabilityMulti-year revenue declines and a collapse in net margin to near zero indicate weakening core economics. Persistent top-line pressure limits operating leverage and cash generation upside, forcing reliance on cost cuts or price mix shifts to restore sustainable profitability.
EMEA DTC Weakness & Product Segment IssuesA meaningful EMEA DTC drop and flagged issues in boots and sandals point to structural demand or assortment problems in a key market. Prolonged regional or category underperformance undermines global brand growth and raises execution risk for multi-quarter recovery plans.
Sharp Decline In Return On EquityA dramatic ROE decline signals worsening efficiency of capital deployment and weak shareholder returns. If sustained, it may constrain investor confidence and limit capacity to fund growth internally, forcing more conservative capital allocation or higher-cost financing.
Dr. Martens Plc News
DOCS FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest share price was 43.02 p and its highest was 100.87 p in the past 12 months.
What is Dr. Martens Plc’s market cap?
Dr. Martens Plc’s market cap is £604.61M.
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is May 28, 2026 which is in 71 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on Nov 20, 2025. The company reported -0.009 p earnings per share for the quarter, the consensus estimate of -0.009 p by 0 p.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Semiannually dividend of 0.85 p which represents an annual dividend yield of 3.36%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is 0.05.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 967,343,750 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of -0.009 p in its last earnings report, expectations of -0.009 p. Following the earnings report the stock price went down -9.558%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in GB:DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Martens Plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£93.75 (49.88% Upside)
£93.75 (49.88% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.81%
12-Months-Change
Fundamentals
Return on Equity
4.61%
Trailing 12-Months
Asset Growth
-6.57%
Trailing 12-Months
Company Description
Dr. Martens Plc
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
DOCS Stock 12 Month Forecast
Average Price Target
93.75 p
▲(49.88% Upside)
Technical Analysis
Options Prices
Currently, No data available
---